HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $453,211 | -14.3% | 3,917 | -23.8% | 0.02% | -8.7% |
Q2 2023 | $528,915 | -98.1% | 5,143 | -98.0% | 0.02% | -98.2% |
Q1 2023 | $28,257,971 | -13.4% | 258,915 | -9.7% | 1.30% | -19.1% |
Q4 2022 | $32,619,632 | +26.3% | 286,640 | -31.3% | 1.60% | +15.2% |
Q3 2022 | $25,833,000 | +8.5% | 417,409 | +39.8% | 1.39% | +13.0% |
Q2 2022 | $23,809,000 | -24.5% | 298,507 | -0.4% | 1.23% | -13.4% |
Q1 2022 | $31,530,000 | -3.0% | 299,685 | -0.7% | 1.42% | +7.2% |
Q4 2021 | $32,519,000 | -5.0% | 301,773 | -3.4% | 1.32% | -10.4% |
Q3 2021 | $34,233,000 | +16.0% | 312,513 | -0.9% | 1.48% | +19.4% |
Q2 2021 | $29,522,000 | -17.8% | 315,272 | -19.2% | 1.24% | -18.6% |
Q1 2021 | $35,917,000 | +21.1% | 390,233 | -3.7% | 1.52% | +19.1% |
Q4 2020 | $29,654,000 | -19.0% | 405,383 | -13.9% | 1.28% | -24.6% |
Q3 2020 | $36,593,000 | +27.0% | 471,069 | -9.1% | 1.69% | +23.1% |
Q2 2020 | $28,810,000 | +1099.4% | 518,353 | +539.3% | 1.37% | +925.4% |
Q1 2020 | $2,402,000 | – | 81,083 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |